Clinical Trial Update: HIV Therapeutic DNA Vaccine (ICVAX) Phase I Clinical Trial in Hong Kong [Phase 1]

View source ↗

Summary

A Phase I clinical trial in Hong Kong is evaluating the HIV therapeutic DNA vaccine ICVAX, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• ICVAX (HIV therapeutic DNA vaccine)

Snippet

Sponsor: Immuno Cure Holding (HK) Limited | Conditions: Human Immunodeficiency Virus, Human Immunodeficiency Virus I Infection | Phase 1 | Status: RECRUITING